0.608
2.17%
0.0129
Dopo l'orario di chiusura:
.61
0.002
+0.33%
Protagenic Therapeutics Inc Azioni (PTIX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
43.40%
1.7384
|
1.2122 | 1.4317 | 1.1437 | 0.7393 |
Operating Income/Loss |
43.40%
-1.7384
|
-1.2122 | -1.4317 | -1.1437 | -0.7393 |
Nonoperating Income/Loss |
103.03%
0.0141
|
-0.464 | 0.0351 | -0.0658 | 0.0212 |
Income/Loss From Continuing Operations Before Tax |
2.87%
-1.7243
|
-1.6762 | -1.3966 | -1.2096 | -0.7181 |
Income/Loss From Continuing Operations After Tax |
2.87%
-1.7243
|
-1.6762 | -1.3966 | -1.2096 | -0.7181 |
Net Income/Loss
|
2.87%
-1.7243
|
-1.6762 | -1.3966 | -1.2096 | -0.7181 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
26,850%
4.4351
|
0.0165 | 4.331 | 4.331 | 4.3179 |
Diluted Average Shares |
26,850%
4.4351
|
0.0165 | 4.331 | 4.331 | -0.00429 |
Basic Earnings Per Share |
2.63%
-0.39
|
-0.38 | -0.32 | -0.28 | -0.17 |
Diluted Earnings Per Share |
2.63%
-0.39
|
-0.38 | -0.32 | -0.28 | -0.17 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):